Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like TikTok influencers promote cycle syncing, but where’s the evidence? March 18, 2025 Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients June 18, 2024 Back-to-basics, not fad diets beat heart disease and diabetes June 4, 2025